Jeh C. Johnson - 19 May 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
19 May 2023
Net transactions value
+$2,150
Form type
4
Filing time
18 Dec 2023, 17:20:05 UTC
Previous filing
27 Apr 2023
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Purchase $879 +17 +0.68% $51.69 2,526 19 May 2023 Direct F1
transaction MET Common Stock Award $1,271 +19 +0.75% $66.90 2,545 14 Dec 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed by an unaffiliated broker for an account of the reporting person. The broker did not discuss this transaction with the reporting person at the time the trades were made and the reporting person only recently became aware that such transaction had occurred.
F2 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Remarks:

The reporting person's disclosure rounds deferred shares to the nearest whole number.